Cardiogenic Shock Clinical Dossier

Impella 2.5™, Impella CP®, Impella 5.0™, and Impella LD™ heart pumps are now  FDA indicated to provide treatment of ongoing cardiogenic shock. In this setting, the Impella heart pumps have the ability to stabilize the patient’s hemodynamics, unload the left ventricle, perfuse the end organs, and allow for recovery of the native heart.